Hector Marquez, M.D. Anesthesiology Medicare: May Accept Medicare Assignments Practice Location: 2204 Wilborn Ave, South Boston, VA 24592 Phone: 434-517-3139 Fax: 434-572-6716 |
Gregory Alan Shuford, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2204 Wilborn Ave, South Boston, VA 24592 Phone: 434-517-3100 Fax: 434-517-3100 |
Dr. Ming Y. Liu, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2204 Wilborn Ave, South Boston, VA 24592 Phone: 434-517-3100 Fax: 434-517-3602 |
Cesar A Souza, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2204 Wilborn Ave, South Boston, VA 24592 Phone: 434-517-3139 Fax: 434-572-6716 |
News Archive
According to a new study from a team of nurses headed by Melly Turner, R.N., systolic blood pressure can be an average of 14 points higher when taken immediately after arriving in the exam room and sitting on an examination table rather than sitting in a chair with your back supported and feet flat on the floor. In fact, all study participants had lower systolic and diastolic blood pressure measurements when seated in a chair versus the exam table.
Isotechnika Pharma Inc. and Paladin Labs Inc. announced today that they have submitted the dossier and received screening acceptance for VocleraTM (voclosporin) for approval in the Canadian market. VocleraTM is a novel immunosuppressive drug in the class of calcineurin inhibitors and is indicated for the treatment of moderate to severe psoriasis.
Researchers at the Feinstein Institute for Medical Research and the department of neurosurgery at the Hofstra Northwell School of Medicine, announced today that they have published a paper with research findings that could have implications for the treatment of many neurological conditions, including severe traumatic brain injury (TBI).
Physical activity among children and teens is lower than previously thought, and, in another surprise finding, young adults after the age of 20 show the only increases in activity over the lifespan, suggests a study conducted by researchers from the Johns Hopkins Bloomberg School of Public Health.
Micro RNAs (miRNA) have recently emerged as key therapeutic agents against cancers and are actively being evaluated in pre-clinical models of various cancers as well as in human clinical trials.
› Verified 8 days ago